Rationale for active vitamin D analog therapy in senile osteoporosis
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Calcified Tissue International
- Vol. 60 (1) , 100-105
- https://doi.org/10.1007/s002239900195
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Vitamin D receptor gene alleles and osteoporosis: A contrasting viewJournal of Bone and Mineral Research, 1995
- Prediction of bone density from vitamin D receptor allelesNature, 1994
- 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional levelCytokine, 1992
- Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptorsCell, 1991
- Parathyroid Hormone Down-Regulates 1,25-Dihydroxyvitamin D Receptors (VDR) and VDR Messenger Ribonucleic Acidin Vitroand Blocks Homologous Up-Regulation of VDRin VivoEndocrinology, 1990
- Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidationBiochemical Journal, 1989
- 1,25(OH) 2 ‐Vitamin D 3 receptors: gene regulation and genetic circuitryThe FASEB Journal, 1988
- Heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cellsBiochemical and Biophysical Research Communications, 1988
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988
- Target Cells for 1,25-Dihydroxyvitamin D 3 in Intestinal Tract, Stomach, Kidney, Skin, Pituitary, and ParathyroidScience, 1979